Atrial Fibrillation

Atrial Fibrillation


Put yourself to the test: This week’s quiz questions you about skin disease, diabetes, sarcoidosis, atrial flutter, and pain medications.

A recent study found the lower cost to be the result of fewer episodes of major bleeding in patients treated with apixaban.

Post hoc analysis of the ENGAGE AF-TIMI 48 study looked at safety and efficacy of a novel oral anticoagulant in distinct groups with paroxysmal, persistent, or permanent atrial fibrillation.

A new study finds that ablation for atrial flutter reduces hospital-based costs, symptoms, and risk of atrial fibrillation. For stroke risk? Continue anticoagulation.

. . . . And then there’s lipoprotein(a), a diagnostic puzzle that involves acute abdominal pain and a CT scan in a woman with a complicated medical history, and skin lesions that look like coins. 5 questions in all. . . .

Results from the CRYSTAL-AF study find that nearly one-third of patients who experience cryptogenic stroke may have undetected atrial fibrillation.

A recent white paper declares it time to abolish the ambiguous term. Given current knowledge of atrial fibrillation, the 60-year-old description serves only to confuse.


Subscribe to Atrial Fibrillation on [sitename]
Please Wait 20 seconds or click here to close